Top compounds associated with response to RP4-576H24.4


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.0047 0.9
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0036 0.9
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0031 0.9
mRNA CD-437 CTRPv2 pan-cancer AAC 0.003 0.9
mRNA AT13387 CTRPv2 pan-cancer AAC -0.0038 0.9
mRNA WP1130 CTRPv2 pan-cancer AAC 0.0028 0.9
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0027 0.9
mRNA NSC23766 CTRPv2 pan-cancer AAC 0.0027 0.9
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.0029 0.9
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0026 0.9
Download CSV